Abstract
Background and Objectives: Oral health-related quality of life (OHRQOL) is compromised during the post-implant healing period, especially when vertical augmentation is required. A long-term trial sought to evaluate a short dental implant system with an apically expandable macro-design. Materials and Methods: Over 4.5 years, patients with limited vertical alveolar bone were consecutively recruited into this prospective cohort study. Implant success rate, OHRQOL (Oral Health Impact Profile (OHIP)-14), implant stability, and crestal bone changes were evaluated. Results: Data from 30 patients (mean age: 64.6 years, range 44–83) were analyzed, which related to 104 implants (53 in the maxilla, 51 in the mandible). Over the mean follow-up (42.6 ± 16.4 months), the implant success rate was 94.7% in the mandible (two implants lost) and 83.6% in the maxilla (four implants lost; p = 0.096), and the prosthetic success rate was 100%. The median OHIP-14 scores improved from 23 (interquartile range (IQR) 9–25.5) to 2 (IQR 0–5; p < 0.001). The mean implant stability quotient (ISQ) was 71.2 ± 10.6 for primary stability and 73.7 ± 13.3 (p = 0.213) for secondary stability, without significant maxilla-versus-mandible differences (p ≥ 0.066). Compared to the baseline, median crestal bone changes after loading were 1.0 mm (IQR 0–1.3) and 1.0 mm (IQR 0.2–1.2) in the maxilla and mandible (p = 0.508), respectively, at the end of the first year, 1.1 mm (IQR 0–1.3) and 1.0 mm (IQR 0.1–1.2) (p = 0.382), respectively, at the end of the second year, and 1.2 mm (IQR 0–1.9) and 1.1 mm (IQR 0.1–1.2) (p = 0.304), respectively, at the end of the third year. Conclusions: In patients with limited vertical bone height, short implants with optimized macro-design constitute a reliable method for functional rehabilitation, avoiding extensive alveolar bone augmentation.
Highlights
In patients with limited vertical bone height, short implants with optimized macro-design constitute a reliable method for functional rehabilitation, avoiding extensive alveolar bone augmentation
The treatment process is extensive for patients with limited vertical alveolar bone height because augmentation procedures are required prior to implanting standard dental implants [1]
Our findings indicate a relevant increase in Oral health-related quality of life (OHRQOL), suggesting successful patient-based oral rehabilitation, which aligns with results reported by John et al [27] and Reißmann et al [49]
Summary
The treatment process is extensive for patients with limited vertical alveolar bone height because augmentation procedures are required prior to implanting standard dental implants [1]. The remodeling of augmented alveolar ridges occurs with volume loss, due to the remodeling or uncertain predictability of various developed procedures. The prognosis of short dental implants and patient satisfaction with this treatment have been predictably high [6,7,8,9]. Oral health-related quality of life (OHRQOL) is compromised during the post-implant healing period, especially when vertical augmentation is required. Materials and Methods: Over 4.5 years, patients with limited vertical alveolar bone were consecutively recruited into this prospective cohort study. OHRQOL (Oral Health Impact Profile (OHIP)-14), implant stability, and crestal bone changes were evaluated
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.